We are international
Donate
TEXT SIZE   


Myeloma Minute
February 19, 2015
02.19.15
February 19, 2015
Share the Minute Facebook Tweet!
Clinical Trials
Donate to the IMF
 

 


This week's question: What are some treatment options for the t(4;14) abnormality?

Multiple Myeloma Bone Study

 

 

Upcoming Events


Saturday, March 7, 2015
Regional Community Workshop Denver, Colorado


Saturday, March 7, 2015
Zumba for Multiple Myeloma
St. Augustine, Florida


Friday, March 13, 2015
2015 Kubik Multiple Myeloma Benefit
Rowlett, Texas


Saturday, March 14, 2015 Regional Community Workshop
San Diego, California


Saturday, March 14, 2015
Art-on-the-Gogh
Virginia Beach, Virginia


Friday - Saturday,
March 27 - 28, 2015

Patient & Family Seminar
San Francisco, California


Saturday, April 11, 2015
Myeloma Center Workshop
Dallas, Texas

 
Watch the IMF Mambo for Myeloma & Support This Challenge

 

 

 

 

x

FDA Approves Revlimid® for Newly Diagnosed Myeloma


 

There was important news for myeloma patients this week as the US Food and Drug Administration approved Revlimid in combination with dexamethasone for newly diagnosed myeloma patients. Revlimid has already been in frontline use off-label in the US, but as IMF Chairman Dr. Brian Durie writes, the new approval raises “many issues which will limit ideal global access and use.” CLICK HERE to read Dr. Durie's blog.

x

New IMWG Assessment System for Elderly Myeloma Patients

 

The IMF’s research arm, the International Myeloma Working Group (IMWG), published an important new study on the assessment of elderly myeloma patients in the journal Blood. In the paper, the IMWG introduces a scoring system developed to classify the frailty of elderly patients. The international study, which analyzed data from more than 850 newly diagnosed patients, found that the IMWG frailty score predicted mortality and the risk of toxicity in elderly myeloma patients. The frailty score could be a helpful tool in better assessing patients and providing them with more suitable therapies. CLICK HERE to read the report.

x
 

March for Myeloma Awareness Month


 

In preparation for Myeloma Awareness Month (#MAM) many myeloma support groups are signing up to march in their local St. Patrick's Day parades to spread awareness in their communities. The first group all set to celebrate #MAM in this way is Waterbury, Connecticut-based support group, the Connecticut Multiple Myeloma Fighters. Join them on Sunday, March 15th for the Greater New Haven St. Patrick's Day Parade. If you'd like to join the march, contact Robin Tuohy at rtuohy@myeloma.org. You can also watch the parade live on WCCT starting at 2pm EST. CLICK HERE for a list of all planned #MAM events.

x
 

Where To Go With Your Myeloma Questions?


 

Have a question about myeloma? The IMF has a number of resources available to help. For time-sensitive questions, call the IMF's InfoLine, a toll-free support system run by knowledgeable members of the IMF staff, 800-452-CURE (2873) from 9 am to 4 pm PST. You can also email the InfoLine team less time-sensitive questions at infoline@myeloma.org. While InfoLine coordinators cannot give medical advice or guidance, they can provide you with information about myeloma, its treatments, side effects and management of side effects, clinical trial information, and referrals to specialists and myeloma-specific support groups.  #AskDrDurie is the IMF’s weekly web series, hosted by IMF Chairman Dr. Brian Durie, which answers questions of broad audience interest about myeloma. Questions submitted to AskDrDurie@myeloma.org will be reviewed for possible inclusion in this web series.

 x

Join Our Mailing List

 

 

 

 

 

 

 

 

 

 

 

12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF Hotline: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe
www.myeloma.org

 related articles